Involvement of PTEN mutations in the genetic pathways of colorectal cancerogenesis

Human Molecular Genetics

Volumn 9, Issue 2, 2000, Pages 283-287

  Guanti, Ginevra ^b   Resta, Nicoletta ^b   Simone, Cristiano ^b   Cariola, Filomena ^a   Demma, Ignazio ^a   Fiorente, Paola ^a   Gentile, Mattia ^a  

^a NATIONAL INSTITUTE FOR DIGESTIVE DISEASES   (Italy)

^b POLICLINICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MICROSATELLITE DNA;

ARTICLE; CANCER GENETICS; CLINICAL ARTICLE; COLON CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; EXON; FRAMESHIFT MUTATION; GENE FUNCTION; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; MICROSATELLITE INSTABILITY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOMATIC MUTATION; TUMOR SUPPRESSOR GENE;

EID: 0033984095     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/9.2.283     Document Type: Article

References (20)

1. Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S.I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R. et al. (1997) PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science, 275, 1943-1947.
2. Steck, P.A., Pershouse, M.A., Jasser, S.A., Yung, W.K., Lin, H., Ligon, A.H., Langford, L.A., Baumgard, M.L., Hattier, T., Davis, T. et al. (1997) Identification of a candidate tumour suppressor gene, MMACI, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nature Genet., 15, 356-362.
3. Li, D.M. and Sun, H. (1997) TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor β. Cancer Res., 57, 2124-2129.
4. Liaw, D., Marsh, D.J., Li, J., Dahia, P.L., Wang, S.I., Zheng, Z., Bose, S., Call, K.M., Tsou, H.C., Peacocke, M. et al. (1997) Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nature Genet., 16, 64-67.
5. Marsh, D.J., Dahia, P.L., Zheng, Z., Liaw, D., Parsons, R., Gorlin, R.J. and Eng, C. (1997) Germline mutations in PTEN are present in Bannayan-Zonana syndrome. Nature Genet., 16, 333-334.
6. Kong, D., Suzuki, A., Zou, T., Sakurada, A., Kemp, L., Wakatsuki, S., Yokoyama, T., Yamakawa, S., Furukawa, T., Sato, M. et al. (1997) PTENI is frequently mutated in primary endometrial carcinomas. Nature Genet., 17, 143-144.
7. Wang, Z.J., Taylor, F., Churchman, M., Norbury, G. and Tomlinson, I. (1998) Genetic pathways of colorectal carcinogenesis rarely involve the PTEN and LKB1 genes outside the inherited hamartoma syndromes. Am. J. Pathol., 153, 363-366.
8. Okami, K., Wu, L., Riggins, G., Cairns, P., Goggins, M., Evron, E., Halachmi, N., Ahrendt, S.A., Reed, A.L., Hilgers, W. et al. (1998) Analysis of PTEN/MMACI alterations in aerodigestive tract tumors. Cancer Res., 58, 509-511.
9. Chang, J.G., Chen, Y.J., Perng, L.I., Wang, N.M., Kao, M.C., Yang, T.J., Chang, C.P. and Tsai, C.H. (1999) Mutation analysis of the PTEN/MMACI gene in cancers of the digestive tract. Eur. J. Cancer, 35, 647-651.
10. Risinger, J.I., Hayes, A.K., Berchuck, A. and Barrett, J.C. (1997) PTEN/ MMACI mutations in endometrial cancers. Cancer Res., 57, 4736-4738.
11. Wang, Y.E., Wu, X., Suzuki, H., Reiter, R.E., Tran, C., Vessella, R., Said, J.W., Isaac, B.W. and Sawyers, C. (1998) Inactivation of the tumor suppressor PTEN/MMACI in advanced human prostate cancer through loss of expression. Proc. Natl Acad. Sci. USA, 95, 5246-5250.
12. McManemin, M.E., Soung, P., Perera, S., Kaplan, I., Loda, M. and Sellers, W.L. (1999) Loss of PTEN expression in paraffin-embedded primary prostate cancer correlates with high Gleason score and advanced stage. Cancer Res., 59, 4291-4296.
13. Marsh, D.J., Coulon, V., Lunetta, K.L., Rocca-Serra, P., Dahia, P.M.L., Zheng, Z., Liaw, D., Caron, S., Duboué, B., Lin, A.Y. et al. (1998) Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation. Hum. Mol. Genet., 7, 507-519.
14. Marsh, D.J., Kum, J.B., Lunetta, K.L., Bennett, M.J., Gorlin, R.J., Ahmed, S.F., Bodurtha, J., Crowe, C., Curtis, M.J., Dasouki, M. et al. (1999) PTEN mutations spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome. Hum. Mol. Genet., 8, 1461-1472.
15. Di Cristofano, A., Pesce, B., Cordon-Cardo, C. and Pandolfi, P.P. (1998) PTEN is essential for embryonic development and tumor suppression. Nature Genet., 19, 348-355.
16. Tamura, M., Gu, J., Matsumoto, K., Aota, S., Parsons, R. and Yamada, K.M. (1998) Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science, 280, 1614-1617.
17. Maehama, T. and Dixon, J.E. (1998) The tumor suppressor, PTEN/ MMACI, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-triphosphate. J. Biol. Chem., 273, 13375-13378.
18. Stambolic, V., Suzuki, A., de la Pompa, J.L., Brothers, G.M., Mirtsos, C., Sasaki, T., Ruland, J., Penninger, J.M., Siderovski, D.P. and Mak, T.W. (1998) Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell, 95, 29-39.
19. Yamamoto, H., Sawai, H. and Perucho, M. (1997) Frameshift somatic mutations in gastrointestinal cancer of microsatellite mutator phenotype. Cancer Res., 57, 4420-4426.
20. Groden, J., Thliveris, A., Samowitz, W., Carlson, M., Gelbert, L., Albertsen, H., Joslyn, G., Stevens, J., Spirio, L., Robertson, M. et al. (1991) Identification and characterization of the familial adenomatous polyposis coli gene. Cell, 66, 589-600.